Help us create more content like this
Already a member? Sign in.
Quinhi Nantot
Guinea-Bissau halts U.S.-backed newborn hepatitis B trial over ethical concerns
Guinea-Bissau has put a halt to a U.S.-backed hepatitis B vaccine study involving newborns, pending a formal ethical assessment, the country’s health minister announced on Thursday. Health Minister Quinhi Nantot said the trial moved forward without review by the country’s full ethics panel, noting that a six-member committee did not convene during the project’s initial…
